Chronic Illness Articles
IVIG has enhanced and even saved the lives of many autoimmune disease patients. But, the cost of therapy, large dose size and limited raw materials are serious limitations to an otherwise efficacious, well-tolerated therapy.
Current treatments for PANDAS have been shown to be relatively effective, but could surgical treatments such as tonsillectomy and adenoidectomy offer more effective results?
Will the evolving therapeutic guidelines for treating diabetes, as well as managing its risks and complications, stem the tide of this costly and sometimes deadly disease?
For decades, donor blood stem cell transplantation has been the only potential cure for severe primary immunodeficiency disorders, but it has been limited by failure and serious complication risks. Now, a trifecta of scientific advances is transforming the prognosis for children once defenseless against life-threatening infections.
Grifols, the world’s third largest manufacturer of plasma-based therapeutics and a leader in immunohematology and transfusion medicine diagnostics, has been patiently developing a novel approach to treatment of AD, based on plasma exchange and replacement with donor human albumin.
There is no effective treatment for this devastating disease, but research is paving the way for better diagnostic methods and new therapies to prevent, slow or stop it.
Scientific breakthroughs using gene therapy are allowing physicians to take a “precision medicine” approach to treating cancer — with promising results.
For resuscitation of patients with sepsis, the verdict is in: Hydroxyethyl starch products increase the risk of acute kidney injury and death.
Early referral for workup of patients with any of more than 150 occult primary immunodeficiency diseases can dramatically reduce hospitalizations, permanent disability and high costs of care.
While a cure remains elusive, strides in treatment options are increasingly controlling symptoms and giving patients a positive long-term prognosis.
